Johnson & Johnson Found Significantly Overvalued by GuruFocus Analysis

Johnson & Johnson (JNJ) has seen significant price appreciation over the past year, with a 32.0% increase in its stock value so far this year and a remarkable 54.8% rise over the last year. However, an analysis conducted by GuruFocus reveals that JNJ is significantly overvalued according to various valuation models.

The DCF earnings-based intrinsic value of JNJ is estimated at $123.97, while its current price stands at $270.24, resulting in a margin of safety of -118.0%. The free cash flow (FCF)-based intrinsic value for JNJ is calculated to be $105.26, which also indicates overvaluation.

The GF ValueTM for JNJ is $192.59, providing another perspective on the stock's valuation. All three models, DCF earnings, DCF FCF, and GF ValueTM, agree that JNJ is overvalued, highlighting a significant discrepancy between its market price and intrinsic value.